Results 61 to 70 of about 15,713 (203)

Alpha‐Synuclein Promotes Anterograde Vesicle Transport in Melanocytes and Melanoma Cells: A Pro‐Survival Function

open access: yesJournal of the Chinese Chemical Society, EarlyView.
Model for how α‐syn modulates the positioning of endolysosomes in melanoma cells. (a) α‐syn tethers endolysosomes to the plasma membrane, a last step in anterograde transport. (b) Loss of α‐syn expression causes the loss of the tethering function, which leads to perinuclear vesicle clustering. Reproduced from the open access article.
Stephan N. Witt
wiley   +1 more source

Structural variants in SNCA gene and the implication to synucleinopathies [PDF]

open access: yesCurrent Opinion in Genetics & Development, 2017
Synucleinopathies are a group of neurodegenerative diseases that share a common pathological lesion of intracellular protein inclusions largely composed of aggregates of alpha-synuclein protein. Accumulating evidence, including genome-wide association studies, has implicated the alpha-synuclein (SNCA) gene in the etiology of synucleinopathies and it ...
openaire   +2 more sources

Socio‐Occupational Functioning after Subthalamic Deep Brain Stimulation in Parkinson's Disease

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Socio‐occupational functioning in patients with Parkinson's disease (PD) treated with subthalamic nucleus deep brain stimulation (STN‐DBS) is not fully captured by standard motor and quality‐of‐life scales. Objectives To characterize patient‐reported socio‐occupational functioning after STN‐DBS and explore associated clinical and ...
Gabriele Imbalzano   +7 more
wiley   +1 more source

Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey

open access: yes, 2021
Introduction: Mutations in the LRRK2 and alpha-synuclein (SNCA) genes are well-established causes of autosomal dominant Parkinson's disease (PD). However, their frequency differs widely between ethnic groups.
Hanagasi, Haşmet Ayhan   +10 more
core   +1 more source

Targeted attenuation of elevated histone marks at SNCA alleviates α‐synuclein in Parkinson's disease

open access: yesEMBO Molecular Medicine, 2021
Epigenetic deregulation of α‐synuclein plays a key role in Parkinson’s disease (PD). Analysis of the SNCA promoter using the ENCODE database revealed the presence of important histone post‐translational modifications (PTMs) including transcription ...
Subhrangshu Guhathakurta   +8 more
doaj   +1 more source

Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment

open access: yes, 2015
SNCA/α-synuclein aggregation plays a crucial role in synucleinopathies such as Parkinson disease and dementia with Lewy bodies. Aggregating and nonaggregating SNCA species are degraded by the autophagy-lysosomal pathway (ALP).
Wei Xiang (46368)   +10 more
core   +1 more source

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA [PDF]

open access: yesFrontiers in Aging Neuroscience, 2017
Objective: Hyposmia may occur simultaneously with REM sleep behavior disorder (RBD) as a specific phenotype in Parkinson's Diseases (PD), of which the disease progression is fast. In the study, we tried to identify whether the genotypic characteristics could participate in the co-occurrence of hyposmia and RBD in PD patients.
Li, Yuanyuan   +5 more
openaire   +3 more sources

Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease

open access: yesDisease Models & Mechanisms, 2017
Parkinson's disease (PD) is a frequent neurodegenerative process in old age. Accumulation and aggregation of the lipid-binding SNARE complex component α-synuclein (SNCA) underlies this vulnerability and defines stages of disease progression. Determinants
Suna Lahut   +29 more
doaj   +1 more source

Disease‐Duration–Specific Percentiles for Prospective Subtyping of Parkinson's Disease: A PPMI‐Based Study

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is clinically heterogeneous, with variable progression rates that complicate clinical trial design. The data‐driven diffuse malignant (DM), intermediate (IM), and mild‐motor predominant (MMP) subtyping model has prognostic value but lacks disease duration–specific thresholds for prospective use in disease ...
Ahmed Negida   +4 more
wiley   +1 more source

Reducing effect of insulin resistance on alpha-synuclein gene expression in skeletal muscle

open access: yesDiabetology & Metabolic Syndrome, 2019
Background Alpha-synuclein (SNCA) as the presynaptic protein is expressed in different tissues and prevents insulin-resistance (IR) through increasing glucose-uptake by adipocytes and muscles.
Amirhosein Khoshi   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy